---
title: "GLAXOSMITHKLINE PLC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c50c635a-a057-547c-90cd-d21ec818140c
json: https://whiteintel.dev/api/public/dossier/c50c635a-a057-547c-90cd-d21ec818140c
identifier: sec:0001131399
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GLAXOSMITHKLINE PLC

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001131399`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c50c635a-a057-547c-90cd-d21ec818140c  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c50c635a-a057-547c-90cd-d21ec818140c  

## Ownership & control

### Holdings / subsidiaries

- **Wave Life Sciences Ltd.** (tenpercentowner) — https://whiteintel.dev/entity/c91f2c7e-e155-5164-9675-96440c9c6d62
- **23andMe Holding Co.** (tenpercentowner) — https://whiteintel.dev/entity/252e0929-8b97-5dc5-badb-c6b512928f0d
- **Spero Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/3e182f58-b9a6-5ea2-96df-347de93659e3
- **Theravance Biopharma, Inc.** (other) — https://whiteintel.dev/entity/d7255ed9-d961-59e3-906e-8f659740f843
- **CVRx, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/aba490fa-e76d-57bf-b0cf-204c1d8dc45a
- **Lyell Immunopharma, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/eeb1283f-805a-5e39-98c5-0756afaf7715
- **Innoviva, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/1fc7f1be-5f35-5f88-bd49-2a493e9f2008
- **DECIBEL THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/62f3ae6d-d1ff-57f3-bc17-1dec97ac0fcd
- **DECIBEL THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/62f3ae6d-d1ff-57f3-bc17-1dec97ac0fcd
- **PANDION THERAPEUTICS HOLDCO LLC** (tenpercentowner) — https://whiteintel.dev/entity/060b1392-136a-5cbf-a2ea-51a04af26d41
- **Nkarta, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/3ebe47b2-1755-5682-a49d-3331c6f8189a
- **PANDION THERAPEUTICS HOLDCO LLC** (director) — https://whiteintel.dev/entity/060b1392-136a-5cbf-a2ea-51a04af26d41

…and **44** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GLAXOSMITHKLINE PLC** — https://whiteintel.dev/entity/c50c635a-a057-547c-90cd-d21ec818140c · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GLAXOSMITHKLINE PLC**. Human view: https://whiteintel.dev/entity/c50c635a-a057-547c-90cd-d21ec818140c · Structured JSON: https://whiteintel.dev/api/public/dossier/c50c635a-a057-547c-90cd-d21ec818140c._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._